Intrinsic value of Rocket Pharmaceuticals, Inc. (RCKT)
Live fair value data for Rocket Pharmaceuticals, Inc. (RCKT) is currently unavailable. Please check again shortly.
Current Price: $198.00
Valuation: Undervalued
Confidence: 6.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Rocket Pharmaceuticals, Inc. (RCKT) undervalued or overvalued?
Based on the current model output, Rocket Pharmaceuticals, Inc. appears to be undervalued with a upside of 21.00%.
Fair value vs market price — Rocket Pharmaceuticals, Inc. (RCKT)
Unlock premium access to view the live fair value comparison against current market price for RCKT.
Frequently Asked Questions - RCKT
How is RCKT intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for RCKT.
Is RCKT undervalued or overvalued right now?
RCKT is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for RCKT: open their intrinsic value pages.